News

Prostate Cancer Choice

Watch Philadelphia CyberKnife Medical Director John Lamond, M.D. talk about how Philadelphia CyberKnife was the first to bring CyberKnife technology to the greater Philadelphia region over ten years ago. They are the most experienced CyberKnife team in the area and you can trust them to treat your prostate cancer in five nonsurgical treatment sessions. It's Your Prostate. Your Cancer. Your Choice. For more information on how Philadelphia CyberKnife treats prostate cancer with CyberKnife technology, please call 888-CyberMe or visit www.MyCyberKnife.com today!

The Importance of Getting a Second Opinion

A recent article from CancerConnect.com, a patient-focused cancer website, suggests that if you have been diagnosed with cancer, seeking a second opinion will allow you to learn more about your cancer type and make truly informed decisions about treatment.

ASTRO Updates Clinical Guidance on Accelerated Radiation Therapy for Breast Cancer

The American Society for Radiation Oncology (ASTRO), the premier radiation oncology society in the world, recently updated their guidelines for accelerated partial breast irradiation (APBI) in the treatment of patients with early-stage breast cancer.

Philadelphia CyberKnife Hosts Survivorship Celebration

On Thursday, September 8, the physicians and staff from Philadelphia CyberKnife hosted a survivorship celebration to recognize and honor the cancer survivors treated at the center.

Philadelphia CyberKnife Welcomes Olusola Obayomi-Davies, M.D. to Physician Team

Philadelphia CyberKnife announced that Olusola Obayomi-Davies, M.D. will be joining their cancer care treatment team.

Philadelphia CyberKnife Now Accepting Patients for Partial Breast Irradiation Study

Recently, Philadelphia CyberKnife, in cooperation with the department of Radiation Medicine at Georgetown University Hospital, started to evaluate accelerated partial breast irradiation delivered with the CyberKnife® Robotic Radiosurgery System in early stage breast cancer in five treatments through a registry study.

Luther W. Brady, M.D. Inducted Into The Spanish Royal Academy of Medicine

Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Luther W. Brady, M.D. is being made an Extraordinary International Academic Member of the Spanish Royal Academy of Medicine.

Luther W. Brady, M.D. Awarded Seventh Honorary Degree

Greg Spurlock, President of Alliance Oncology, announced today that Luther W. Brady M.D., Director of Medical Research at The CyberKnife Center of Philadelphia, is being awarded his seventh honorary degree from Complutense University in Madrid, Spain.

CyberKnife® Robotic Radiosurgery Offers Equal Success Rates, Shorter Treatment Times Compared to Intensity Modulated Radiation Therapy (IMRT)

Crozer-Keystone Health System recently issued a press release about a new study that has found that the CyberKnife Robotic Radiosurgery System is able to offer prostate cancer patients success rates equal to intensity modulated radiation therapy (IMRT), with shorter treatment duration and lower total cost.